Stem cell therapy for Parkinson’s boosted by immune Tregs: Study
Scientists have shown that co-transplanting stem cells with regulatory T-cells — immune cells known as Tregs that dampen excessive inflammatory…
Articles by Patricia Inácio, PhD
Plant compounds found to ease Parkinson’s-like symptoms in rats
Plant compounds extracted from the Amomum subulatum fruit, also known as greater cardamom, were found to ease Parkinson’s disease-like…
Two blood biomarkers may help predict risk of Parkinson’s: Study
Scientists have identified a nine-gene signature model to predict the risk of Parkinson’s disease by integrating data from blood…
FDA OKs ENT-01 for patient with multiple system atrophy
The U.S. Food and Drug Administration (FDA) has agreed that a 42-year-old man with prodromal, or early stage, multiple…
Phase 2b trial of pirepemat enrolling patients at 38 clinical sites
Enrollment is now open across all 38 clinical sites in the Phase 2b trial testing pirepemat (previously known as…
New Phase 2 trial of ATH434 in advanced MSA enrolls first patient
Alterity Therapeutics’ new Phase 2 clinical trial testing ATH434 in patients with multiple system atrophy (MSA), a form…
Dosing begins in Phase 2 trial of Bial’s therapy for GBA1 Parkinson’s
The first patient has been dosed in a Phase 2 trial testing BIA 28-6156, Bial’s investigational therapy for…
NurrOn’s joint effort will advance new Nurr1-based treatments
NurrOn Pharmaceuticals has partnered with South Korean HanAll Biopharma and Daewoong Pharmaceutical to continue developing its candidate…
MJFF, H1 working to boost participation in clinical trials
The Michael J. Fox Foundation (MJFF) is partnering with H1 to enhance the connections between physicians, researchers and patients…
Pregnenolone for Parkinson’s seen to ease involuntary movement in rats
The natural brain-produced steroid pregnenolone showed benefits in a rat model of Parkinson’s disease, where it was found…